Lupin informs about press release

01 Oct 2025 Evaluate
Lupin has informed that it enclosed a Press Release as regards, launch of Rivaroxaban for Oral Suspension, 1 mg/mL, in the United States.

The above information is a part of company’s filings submitted to BSE. 

Lupin Share Price

2340.75 39.05 (1.70%)
10-Mar-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1813.00
Dr. Reddys Lab 1313.90
Cipla 1333.10
Zydus Lifesciences 922.90
Lupin 2340.75
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×